| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 16.269 | 20.380 | 18.258 | 18.950 | 17.979 | 16.528 | 17.474 | 16.684 | 11.515 |
| Total Income - EUR | - | 16.269 | 20.380 | 18.258 | 18.950 | 17.979 | 16.528 | 17.474 | 16.684 | 11.515 |
| Total Expenses - EUR | - | 5.593 | 7.715 | 9.722 | 8.300 | 7.262 | 4.895 | 7.129 | 4.291 | 10.380 |
| Gross Profit/Loss - EUR | - | 10.675 | 12.666 | 8.536 | 10.649 | 10.717 | 11.632 | 10.345 | 12.394 | 1.135 |
| Net Profit/Loss - EUR | - | 10.187 | 11.920 | 7.988 | 10.081 | 10.218 | 11.136 | 9.821 | 10.187 | 338 |
| Employees | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Nadiamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 14.474 | 10.546 | 6.737 | 3.061 | 104 | 1.001 | 588 | 1.163 | 30.947 |
| Current Assets | - | 5.502 | 11.557 | 22.645 | 12.018 | 18.820 | 28.572 | 10.030 | 9.393 | 4.808 |
| Inventories | - | 118 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.175 | 662 | 1.503 | 0 | 103 | 0 | 1.078 | 4.623 | 17 |
| Cash | - | 4.209 | 10.895 | 21.142 | 12.018 | 18.716 | 28.572 | 8.952 | 4.769 | 4.791 |
| Shareholders Funds | - | 10.232 | 21.863 | 29.450 | 14.561 | 18.617 | 23.478 | 1.721 | 10.178 | 8.273 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 9.780 | 240 | 236 | 782 | 307 | 6.095 | 8.897 | 378 | 28.815 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nadiamed Srl